Maternal occupational exposure to polycyclic aromatic hydrocarbons and small for gestational age offspring
- PMID: 24893704
- PMCID: PMC4497781
- DOI: 10.1136/oemed-2013-101833
Maternal occupational exposure to polycyclic aromatic hydrocarbons and small for gestational age offspring
Abstract
Objectives: While some of the highest maternal exposures to polycyclic aromatic hydrocarbons (PAHs) occur in the workplace, there is only one previous study of occupational PAH exposure and adverse pregnancy outcomes. We sought to extend this literature using interview data combined with detailed exposure assessment.
Methods: Data for 1997-2002 were analysed from mothers of infants without major birth defects in the National Birth Defects Prevention Study, a large population-based case-control study in the USA. Maternal telephone interviews yielded information on jobs held in the month before conception through delivery. From 6252 eligible control mothers, 2803 completed the interview, had a job, met other selection criteria, and were included in the analysis. Two industrial hygienists independently assessed occupational exposure to PAHs from the interview and reviewed results with a third to reach consensus. Small for gestational age (SGA) was the only adverse pregnancy outcome with enough exposed cases to yield meaningful results. Logistic regression estimated crude and adjusted ORs.
Results: Of the 2803 mothers, 221 (7.9%) had infants who were SGA. Occupational PAH exposure was found for 17 (7.7%) of the mothers with SGA offspring and 102 (4.0%) of the remaining mothers. Almost half the jobs with exposure were related to food preparation and serving. After adjustment for maternal age, there was a significant association of occupational exposure with SGA (OR=2.2, 95% CI 1.3 to 3.8).
Conclusions: Maternal occupational exposure to PAHs was found to be associated with increased risk of SGA offspring.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
References
-
- ATSDR (Agency for Toxic Substances and Disease Registry) Toxicological Profile for Polycyclic Aromatic Hydrocarbons (PAHs) (Update). (Monograph) US Department of Health and Human Services, Public Health Service, Agency for Toxic Substances and Disease Registry; 1995. - PubMed
-
- Brandt HC, Watson WP. Monitoring human occupational and environmental exposures to polycyclic aromatic compounds. Ann Occup Hyg. 2003;47:349–78. - PubMed
-
- Hansen AM, Mathiesen L, Pedersen M, et al. Urinary 1-hydroxypyrene (1-HP) in environmental and occupational studies—a review. Int J Hyg Environ Health. 2008;211:471–503. - PubMed
-
- Sjaastad AK, Svendsen K. Exposure to polycyclic aromatic hydrocarbons (PAHs), mutagenic aldehydes, and particulate matter in Norwegian a la carte restaurants. Ann Occup Hyg. 2009;53:723–9. - PubMed
-
- Madhavan ND, Naidu KA. Polycyclic aromatic hydrocarbons in placenta, maternal blood, umbilical cord blood and milk of Indian women. Hum Exp Toxicol. 1995;14:503–6. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous